873 related articles for article (PubMed ID: 27136297)
1. Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation.
Valiente-Gabioud AA; Miotto MC; Chesta ME; Lombardo V; Binolfi A; Fernández CO
Acc Chem Res; 2016 May; 49(5):801-8. PubMed ID: 27136297
[TBL] [Abstract][Full Text] [Related]
2. Metal coordination and peripheral substitution modulate the activity of cyclic tetrapyrroles on αS aggregation: a structural and cell-based study.
González N; Gentile I; Garro HA; Delgado-Ocaña S; Ramunno CF; Buratti FA; Griesinger C; Fernández CO
J Biol Inorg Chem; 2019 Dec; 24(8):1269-1278. PubMed ID: 31486955
[TBL] [Abstract][Full Text] [Related]
3. Binding Modes of Phthalocyanines to Amyloid β Peptide and Their Effects on Amyloid Fibril Formation.
Valiente-Gabioud AA; Riedel D; Outeiro TF; Menacho-Márquez MA; Griesinger C; Fernández CO
Biophys J; 2018 Mar; 114(5):1036-1045. PubMed ID: 29539391
[TBL] [Abstract][Full Text] [Related]
4. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
5. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
6. Toward the discovery of effective polycyclic inhibitors of alpha-synuclein amyloid assembly.
Lamberto GR; Torres-Monserrat V; Bertoncini CW; Salvatella X; Zweckstetter M; Griesinger C; Fernández CO
J Biol Chem; 2011 Sep; 286(37):32036-44. PubMed ID: 21795682
[TBL] [Abstract][Full Text] [Related]
7. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
[TBL] [Abstract][Full Text] [Related]
8. The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases.
Cremades N; Dobson CM
Neurobiol Dis; 2018 Jan; 109(Pt B):178-190. PubMed ID: 28709995
[TBL] [Abstract][Full Text] [Related]
9. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
10. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
Chaari A; Eliezer D; Ladjimi M
Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
[TBL] [Abstract][Full Text] [Related]
11. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.
Cheng B; Gong H; Xiao H; Petersen RB; Zheng L; Huang K
Biochim Biophys Acta; 2013 Oct; 1830(10):4860-71. PubMed ID: 23820032
[TBL] [Abstract][Full Text] [Related]
14. Autophagy Modulation as a Treatment of Amyloid Diseases.
Mputhia Z; Hone E; Tripathi T; Sargeant T; Martins R; Bharadwaj P
Molecules; 2019 Sep; 24(18):. PubMed ID: 31527516
[TBL] [Abstract][Full Text] [Related]
15. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
[TBL] [Abstract][Full Text] [Related]
16. Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein.
Lee EN; Cho HJ; Lee CH; Lee D; Chung KC; Paik SR
Biochemistry; 2004 Mar; 43(12):3704-15. PubMed ID: 15035641
[TBL] [Abstract][Full Text] [Related]
17. Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms.
Liu T; Bitan G
ChemMedChem; 2012 Mar; 7(3):359-74. PubMed ID: 22323134
[TBL] [Abstract][Full Text] [Related]
18. Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions.
Cieplak AS
PLoS One; 2017; 12(9):e0180905. PubMed ID: 28922400
[TBL] [Abstract][Full Text] [Related]
19. Animal models for prion-like diseases.
Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases.
Limbocker R; Cremades N; Cascella R; Tessier PM; Vendruscolo M; Chiti F
Acc Chem Res; 2023 Jun; 56(12):1395-1405. PubMed ID: 37071750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
